Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).
This report contains market size and forecasts of Inactivated Polio Vaccine in global, including the following market information:
Global Inactivated Polio Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Inactivated Polio Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Inactivated Polio Vaccine companies in 2021 (%)
The global Inactivated Polio Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Government Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Inactivated Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, Panacea Biotec, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inactivated Polio Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inactivated Polio Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inactivated Polio Vaccine Market Segment Percentages, by Type, 2021 (%)
Government
Private Sector
Global Inactivated Polio Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inactivated Polio Vaccine Market Segment Percentages, by Application, 2021 (%)
Pediatrics
Adults
Global Inactivated Polio Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inactivated Polio Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inactivated Polio Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Inactivated Polio Vaccine revenues share in global market, 2021 (%)
Key companies Inactivated Polio Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Inactivated Polio Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals